MedPath

PHARMANET

🇵🇰Pakistan
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:0

Trial Phases

2 Phases

Phase 2:1
Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (50.0%)
Phase 2
1 (50.0%)

Imaging Study of XERECEPT® Treatment for Peritumoral Brain Edema (PBE)

Phase 2
Terminated
Conditions
Peritumoral Brain Edema
PRIMARY MALIGNANT and METASTATIC BRAIN TUMORS
First Posted Date
2008-06-05
Last Posted Date
2009-01-09
Lead Sponsor
PharmaNet
Target Recruit Count
60
Registration Number
NCT00691522

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.